Leisure-Time Running Reduces the Risk of Incident Type 2 Diabetes Article

Full Text via DOI: 10.1016/j.amjmed.2019.04.035 PMID: 31103650 Web of Science: 000493949700042
International Collaboration

Cited authors

  • Wang, Yuehan; Lee, Duck-chul; Brellenthin, Angelique G.; Eijsvogels, Thijs M. H.; Sui, Xuemei; Church, Timothy S.; Lavie, Carl J.; Blair, Steven N.


  • OBJECTIVES: We examined the overall association as well as the dose-response relationship between leisure-time running and incident type 2 diabetes.; METHODS: Participants were 19,347 adults aged 18-100 years who were free of cardiovascular disease, cancer, and diabetes at baseline, and who received at least 2 extensive preventive medical examinations between 1974 and 2006. Running and other types of aerobic physical activity were assessed by self-reported leisure-time activities. Type 2 diabetes was defined as fasting glucose >= 126 mg/dL (7.0 mmol/L), physician diagnosis, or insulin use.; RESULTS: During an average follow-up of 6.5 years, 1015 adults developed type 2 diabetes. Approximately 29.5% of adults participated in leisure-time running at baseline. Runners had a 28% (hazard ratio [HR] 0.72; 95% confidence interval [CI], 0.62-0.84) lower risk of developing type 2 diabetes compared with non-runners during follow-up. The HRs (95% CIs) of type 2 diabetes were 0.98 (0.75-1.28), 0.69 (0.51-0.92), 0.62 (0.45-0.85), 0.78 (0.59-1.04), and 0.57 (0.42-0.79) across quintiles of running time (minutes/week) compared with nonrunners after adjusting for potential confounders, including levels of nonrunning aerobic physical activity. Similar dose-response relationships between running distance (miles/week), frequency (times/week), total amount (MET-minutes/week), and speed (mph) were also observed.; CONCLUSIONS: Participating in leisure-time running is associated with a lower risk of developing type 2 diabetes in adults. Consistent linear dose-response relationships were observed between various running parameters and incident type 2 diabetes, supporting the prescription of running to prevent type 2 diabetes. (C) 2019 Elsevier Inc. All rights reserved.

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 0002-9343

Start page

  • 1225

End page

  • 1232


  • 132


  • 10